Abstract: Methods and systems for matching user information between data sets, while preserving data privacy are provided. Some examples relate to matching subsets of users from a first device to subsets of users from a second device, based on a first set of indications and a second set of indications, respectively, to calculate how long it takes for a user to travel to a location of interest, after the user is provided with directed content. A conversion rate may be determined based on how many instances at which a user travels to the location of interest, within a conversion window, after the user is provided with the directed content. The conversion rate may be compared to a baseline conversion rate to determine a change in conversion rate. The change in conversion rate may correspond to an impact of the directed content in causing the user to travel to the location of interest. User data is not shared from the first device to the second device, and vice-versa.

Abstract: Particular embodiments may provide a method for facilitating access to power dispensers at a charging station by a server. The server receives a request to charge an electric vehicle (EV) at a charging station that has one or more power dispensers. Then, the server identifies a target EV to request disconnection of the power dispenser connected to the target EV based on an assessment of the EVs connected to the power dispensers. The server facilitates communication with a device associated with the user of the target EV, wherein the communication includes transmission of a notification comprising a request to disconnect the power dispenser connected to the target EV. Based on a response indicating acceptance of the request to disconnect the power dispenser, the server transmits signals to stop the power dispenser from charging the target EV and to unlock a charge port of the target EV.

Abstract: The present invention relates to indole and indazole compounds of Formula (I) that activate 5? adenosine monophosphate-activated protein kinase (AMPK). The invention also encompasses pharmaceutical compositions containing these compounds and methods for treating or preventing diseases, conditions, or disorders ameliorated by activation of AMPK.

Abstract: The present invention relates to indole and indazole compounds of Formula (I) that activate 5? adenosine monophosphate-activated protein kinase (AMPK). The invention also encompasses pharmaceutical compositions containing these compounds and methods for treating or preventing diseases, conditions, or disorders ameliorated by activation of AMPK.

Abstract: The present invention relates to indole and indazole compounds of Formula (I) that activate 5? adenosine monophosphate-activated protein kinase (AMPK). The invention also encompasses pharmaceutical compositions containing these compounds and methods for treating or preventing diseases, conditions, or disorders ameliorated by activation of AMPK.

Abstract: The present invention provides compounds of formula (I) the stereoisomers and prodrugs thereof, and the pharmaceutically acceptable salts of the compounds, stereoisomers, and prodrugs, wherein R1, R2, and R3 are as defined herein; pharmaceutical compositions thereof; combinations thereof; and uses thereof in the treatment of, inter alia, conditions, diseases, and symptoms including, inter alia, Alzheimer's Disease, cancer, dementia, depression, diabetes, hair loss, schizophrenia, and stroke.

Abstract: In recognition of the need to develop novel therapeutic agents and efficient methods for the synthesis thereof, the present invention provides novel compounds of general formula (I), and methods for the synthesis thereof. In another aspect, the present invention provides pharmaceutical compositions comprising a compound of formula (I) and a pharmaceutically acceptable carrier. In yet another aspect, the present invention provides methods for treating cancer comprising administering a therapeutically effective amount of a compound of formula (I) to a subject in need thereof.

Abstract: The invention provides compounds of formula 1 wherein R1, R2, R3, and R4 are as defined, and their pharmaceutically acceptable salts. Compounds of formula 1 are indicated to have activity inhibiting cdk5, cdk2, and GSK-3. Pharmaceutical compositions and methods comprising compounds of formula 1 for treating and preventing diseases and conditions comprising abnormal cell growth, such as cancer, and neurodegenerative diseases and conditions and those affected by dopamine neurotransmission.

Abstract: An apparatus for adjusting the head and the foot section of the resting surface of a bed by means of a bellows or a plurality of bellows which are expanded by compressed air and contracted by expelling the compressed air. Due to the particular construction of the compressed air unit and its positioning in a receiving space enclosed by a base plate and an adjusting plate, a self-contained appliance unit is provided which is suitable for use with any bed.